TRVN - TREVENA INC
2.465
-2.560 -103.854%
Share volume: 0
Last Updated: Mon 07 Oct 2024 08:25:42 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$5.02
0.00
0.00%
View ratios
Fiscal Date | 2024-09-30 | |
---|---|---|
Fiscal Quarter | Q3 2024 | |
Report Date | 2024-11-07 | |
Total revenue | 283.000 K | |
Cost of revenue | 114.000 K | |
Gross profit | 169.000 K | |
Operating expenses | 5.746 M | |
Selling general and admin | 3.880 M | |
Research and development | 1.866 M | |
Total expenses | 5.746 M | |
Operating income | -5.577 M | |
Ebit | -5.098 M | |
Pretax income | -4.909 M | |
Income tax | 30.000 K | |
Net income basic | 0.000 | |
Net income | -4.939 M | |